Literature DB >> 10815665

Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.

H C Roberts1, T P Roberts, R C Brasch, W P Dillon.   

Abstract

BACKGROUND AND
PURPOSE: Dynamic contrast-enhanced MR imaging may be used to quantify tissue fractional blood volume (fBV) and microvascular permeability. We tested this technique in patients with brain tumors to assess whether these measurements correlate with tumor histologic grade.
METHODS: Twenty-two patients with newly diagnosed gliomas underwent MR imaging followed by surgery. Imaging consisted of one pre- and six dynamic postcontrast 3D spoiled gradient-recalled acquisition in the steady state data sets after administration of a single dose (0.1 mmol/kg) of contrast material. Signal intensity changes in blood and tissue were kinetically analyzed using a bidirectional two-compartment model, yielding estimates of fBV (mL/cm3) and microvascular permeability (mL/100 cm3 per minute). Stained tumor specimens were scored on a four-point scale (1 = low grade, 4 = high grade).
RESULTS: Histologic examination revealed one grade 1, eight grade 2, seven grade 3, and six grade 4 tumors. fBV values ranged from 0.5% to 13.7%. Permeability values ranged from -0.4 to 18.8, with a strong correlation (r = 0.83) to tumor grade. Despite some overlap between the permeability values of specific tumors from different grades, differences in the mean were statistically significant. There was a weak correlation (r = 0.39) between estimated fBV and tumor grade, and no statistically significant difference among fBV values in any of the groups.
CONCLUSION: This relatively simple method of analysis provides quantitative estimates of fBV and microvascular permeability in human brain tumors, with the permeability being predictive of pathologic grade. The technique can be easily implemented on clinical scanners and may prove useful in the assessment of tumor biology and in therapeutic trials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815665      PMCID: PMC7976746     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  44 in total

Review 1.  Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

Authors:  R Brasch; C Pham; D Shames; T Roberts; K van Dijke; N van Bruggen; J Mann; S Ostrowitzki; O Melnyk
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

2.  Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.

Authors:  T Siegal; R Rubinstein; T Tzuk-Shina; J M Gomori
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

3.  Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability.

Authors:  H C Roberts; M Saeed; T P Roberts; A Mühler; D M Shames; J S Mann; M Stiskal; F Demsar; R C Brasch
Journal:  J Magn Reson Imaging       Date:  1997 Mar-Apr       Impact factor: 4.813

4.  A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.

Authors:  F Demsar; T P Roberts; H C Schwickert; D M Shames; C F van Dijke; J S Mann; M Saeed; R C Brasch
Journal:  Magn Reson Med       Date:  1997-02       Impact factor: 4.668

5.  Correlation between dynamic MRI and outcome in patients with malignant gliomas.

Authors:  E T Wong; E F Jackson; K R Hess; D F Schomer; J D Hazle; A P Kyritsis; K A Jaeckle; W K Yung; V A Levin; N E Leeds
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

6.  Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme.

Authors:  F T Vertosick; R G Selker; S J Grossman; J M Joyce
Journal:  Neurosurgery       Date:  1994-03       Impact factor: 4.654

Review 7.  Extravascular transport in normal and tumor tissues.

Authors:  R K Jain; L E Gerlowski
Journal:  Crit Rev Oncol Hematol       Date:  1986       Impact factor: 6.312

8.  Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.

Authors:  D Kahn; K A Follett; D L Bushnell; M A Nathan; J G Piper; M Madsen; P T Kirchner
Journal:  AJR Am J Roentgenol       Date:  1994-12       Impact factor: 3.959

9.  Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia.

Authors:  J Kucharczyk; Z S Vexler; T P Roberts; H S Asgari; J Mintorovitch; N Derugin; A D Watson; M E Moseley
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

10.  Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence.

Authors:  K L Black; T Emerick; C Hoh; R A Hawkins; J Mazziotta; D P Becker
Journal:  Neurol Res       Date:  1994-04       Impact factor: 2.448

View more
  123 in total

1.  MR imaging of brain tumors: toward physiologic imaging.

Authors:  H C Roberts; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

2.  Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study.

Authors:  H Uematsu; M Maeda; N Sadato; T Matsuda; Y Ishimori; Y Koshimoto; H Kimura; H Yamada; Y Kawamura; Y Yonekura; H Itoh
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

3.  Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging.

Authors:  J D Eastwood; J M Provenzale
Journal:  Neuroradiology       Date:  2003-04-29       Impact factor: 2.804

4.  Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors.

Authors:  Meng Law; Khuram Kazmi; Stephan Wetzel; Edwin Wang; Codrin Iacob; David Zagzag; John G Golfinos; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

Review 5.  The alphabet soup of perfusion CT and MR imaging: terminology revisited and clarified in five questions.

Authors:  Carlos Leiva-Salinas; James M Provenzale; Kohsuke Kudo; Makoto Sasaki; Max Wintermark
Journal:  Neuroradiology       Date:  2012-04-10       Impact factor: 2.804

6.  Permeability assessment of the focused ultrasound-induced blood-brain barrier opening using dynamic contrast-enhanced MRI.

Authors:  F Vlachos; Y-S Tung; E E Konofagou
Journal:  Phys Med Biol       Date:  2010-08-25       Impact factor: 3.609

Review 7.  Texture analysis: a review of neurologic MR imaging applications.

Authors:  A Kassner; R E Thornhill
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

8.  In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.

Authors:  R Jain; J Gutierrez; J Narang; L Scarpace; L R Schultz; N Lemke; S C Patel; T Mikkelsen; J P Rock
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

9.  High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.

Authors:  Italo Aprile; Giorgia Giovannelli; Paola Fiaschini; Marco Muti; Anna Kouleridou; Nevia Caputo
Journal:  Radiol Med       Date:  2015-03-12       Impact factor: 3.469

Review 10.  Imaging of central nervous system tumors in children: advances and limitations.

Authors:  Louis-Gilbert Vézina
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.